Skip to content
Medical Health Aged Care

GPs visiting WA Parliament to help politicians get healthy and improve the health of the state

Royal Australian College of GPs 2 mins read

A delegation of GPs will visit the Parliament of Western Australia today to talk with politicians about improving both their health and the health of Australia’s largest state. 

The visit organised by Australia’s peak general practice body, the Royal Australian College of GPs (RACGP), will see GPs provide health checks to politicians, including risk assessments for diabetes, heart disease, and high cholesterol.  

RACGP WA Chair Dr Ramya Raman said: “Having a regular GP is important for everyone. Seeing your GP when you are well will mean health conditions can be picked up earlier, treated earlier and ultimately, will help reduce the risk of a patient going to hospital. 

“This is also an opportunity for WA’s politicians to learn about what GPs do, and why it’s so important that everyone in our state can access affordable GP care. 

“However, demand for GP care is growing due to our changing demographics, we have an ageing population and an epidemic of chronic disease. We need to build WA’s GP workforce to meet increasing patient needs and implement reforms to improve access to care and quality for patients. 

“RACGP WA is calling on our state government to fund an incentive payment for junior doctors to train as GPs in regional and remote communities to help grow the workforce. 

“We’re also calling for primary care advisory councils to be established to work with local hospitals across WA to improve health outcomes for patients. Better collaboration and communication between hospitals and GPs would lead to better health for people who go to hospital unexpectedly. 

“I’m looking forward to meeting WA’s political leaders and explaining what GPs do for our state. Everyone deserves the quality care you get from a GP who knows you, and your medical history. And government health funding and policy should ensure everyone in our state can access affordable GP care.” 

RACGP WA is calling for the state to: 

  • Provide junior doctors with top up payments of $40,000 to encourage them to train in WA 

  • Improve collaboration and care by establishing primary care advisory councils to work with local hospitals 


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit To unsubscribe from RACGP media releases, click here.

Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 24/06/2024
  • 17:07
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the Most Common…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 24/06/2024
  • 16:20
National Rural Health Alliance

Community-led innovation to revolutionise healthcare access in rural Australia

The National Rural Health Alliance (the Alliance) is delighted that the Minister for Health and Aged Care, the Hon Mark Butler, has today announced…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 24/06/2024
  • 12:25
Jane Morgan Management

Imugene (ASX:IMU) Doses First Patient in Pioneering Phase 1 onCARlytics Trial

Sydney, Australia, 24 June 2024: Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is thrilled to announce the dosing of the first patient in the intravenous (IV) infusion combination arm of its Phase 1 onCARlytics (CF33-CD19) clinical trial. This groundbreaking trial, named OASIS, is being conducted at City of Hope in California and is designed to transform the treatment landscape for patients with advanced solid tumors. The OASIS trial is a world-first, combining a CD19-expressing oncolytic virus with a CD19-targeting drug. The trial aims to recruit 40-45 patients with advanced solid cancers that have metastasized, with preliminary early combination data…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.